404 related articles for article (PubMed ID: 28779028)
1. Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model.
Wang H; Anthony D; Yatmaz S; Wijburg O; Satzke C; Levy B; Vlahos R; Bozinovski S
Clin Sci (Lond); 2017 Sep; 131(18):2347-2362. PubMed ID: 28779028
[TBL] [Abstract][Full Text] [Related]
2. Increased hypothalamic microglial activation after viral-induced pneumococcal lung infection is associated with excess serum amyloid A production.
Wang H; Blackall M; Sominsky L; Spencer SJ; Vlahos R; Churchill M; Bozinovski S
J Neuroinflammation; 2018 Jul; 15(1):200. PubMed ID: 29980196
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.
Siegel ER; Croze RH; Fang X; Matthay MA; Gotts JE
Am J Physiol Lung Cell Mol Physiol; 2021 Jun; 320(6):L1085-L1092. PubMed ID: 33822656
[TBL] [Abstract][Full Text] [Related]
4. 15-Epi-LXA
Sekheri M; El Kebir D; Edner N; Filep JG
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7971-7980. PubMed ID: 32205444
[TBL] [Abstract][Full Text] [Related]
5. Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.
Krishnamoorthy S; Recchiuti A; Chiang N; Fredman G; Serhan CN
Am J Pathol; 2012 May; 180(5):2018-27. PubMed ID: 22449948
[TBL] [Abstract][Full Text] [Related]
6. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury.
Eickmeier O; Seki H; Haworth O; Hilberath JN; Gao F; Uddin M; Croze RH; Carlo T; Pfeffer MA; Levy BD
Mucosal Immunol; 2013 Mar; 6(2):256-66. PubMed ID: 22785226
[TBL] [Abstract][Full Text] [Related]
7. Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function.
Kain V; Ingle KA; Colas RA; Dalli J; Prabhu SD; Serhan CN; Joshi M; Halade GV
J Mol Cell Cardiol; 2015 Jul; 84():24-35. PubMed ID: 25870158
[TBL] [Abstract][Full Text] [Related]
8. Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.
Wu Y; Tu W; Lam KT; Chow KH; Ho PL; Guan Y; Peiris JS; Lau YL
J Virol; 2015 Feb; 89(4):2013-23. PubMed ID: 25428873
[TBL] [Abstract][Full Text] [Related]
9. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice.
Bento AF; Claudino RF; Dutra RC; Marcon R; Calixto JB
J Immunol; 2011 Aug; 187(4):1957-69. PubMed ID: 21724996
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfection.
Reppe K; Radünzel P; Dietert K; Tschernig T; Wolff T; Hammerschmidt S; Gruber AD; Suttorp N; Witzenrath M
Infect Immun; 2015 Dec; 83(12):4617-29. PubMed ID: 26371127
[TBL] [Abstract][Full Text] [Related]
12. Lipoxin Signaling in Murine Lung Host Responses to Cryptococcus neoformans Infection.
Colby JK; Gott KM; Wilder JA; Levy BD
Am J Respir Cell Mol Biol; 2016 Jan; 54(1):25-33. PubMed ID: 26039320
[TBL] [Abstract][Full Text] [Related]
13. Resolvin D1 Dampens Pulmonary Inflammation and Promotes Clearance of Nontypeable Haemophilus influenzae.
Croasdell A; Lacy SH; Thatcher TH; Sime PJ; Phipps RP
J Immunol; 2016 Mar; 196(6):2742-52. PubMed ID: 26843331
[TBL] [Abstract][Full Text] [Related]
14. Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.
Tang H; Liu Y; Yan C; Petasis NA; Serhan CN; Gao H
J Immunol; 2014 Oct; 193(7):3769-78. PubMed ID: 25172497
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses.
Rogerio AP; Haworth O; Croze R; Oh SF; Uddin M; Carlo T; Pfeffer MA; Priluck R; Serhan CN; Levy BD
J Immunol; 2012 Aug; 189(4):1983-91. PubMed ID: 22802419
[TBL] [Abstract][Full Text] [Related]
16. Aspirin-triggered resolvin D1 is produced during self-resolving gram-negative bacterial pneumonia and regulates host immune responses for the resolution of lung inflammation.
Abdulnour RE; Sham HP; Douda DN; Colas RA; Dalli J; Bai Y; Ai X; Serhan CN; Levy BD
Mucosal Immunol; 2016 Sep; 9(5):1278-87. PubMed ID: 26647716
[TBL] [Abstract][Full Text] [Related]
17. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effects of garenoxacin in murine experimental secondary pneumonia by Streptococcus pneumoniae after influenza virus infection.
Fukuda Y; Furuya Y; Nozaki Y; Takahata M; Nomura N; Mitsuyama J
Diagn Microbiol Infect Dis; 2014 Feb; 78(2):168-71. PubMed ID: 24321356
[TBL] [Abstract][Full Text] [Related]
19. Increase of apoptosis in a murine model for severe pneumococcal pneumonia during influenza A virus infection.
Kosai K; Seki M; Tanaka A; Morinaga Y; Imamura Y; Izumikawa K; Kakeya H; Yamamoto Y; Yanagihara K; Tomono K; Kohno S
Jpn J Infect Dis; 2011; 64(6):451-7. PubMed ID: 22116322
[TBL] [Abstract][Full Text] [Related]
20. Premedication with Clarithromycin Is Effective against Secondary Bacterial Pneumonia during Influenza Virus Infection in a Pulmonary Emphysema Mouse Model.
Harada T; Ishimatsu Y; Hara A; Morita T; Nakashima S; Kakugawa T; Sakamoto N; Kosai K; Izumikawa K; Yanagihara K; Mukae H; Kohno S
J Pharmacol Exp Ther; 2016 Sep; 358(3):457-63. PubMed ID: 27489022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
